genOway Stock Deutsche Boerse AG
Stocks
JEH
FR0004053510
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.290 EUR | -1.72% |
|
-2.55% | -7.66% |
| Market Cap | 22.5M 25.88M 20.94M 19.23M 36.31M 2.47B 36.87M 247M 96.87M 1.23B 97.19M 95.06M 4.12B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 29.22M 33.61M 27.19M 24.97M 47.15M 3.21B 47.88M 321M 126M 1.6B 126M 123M 5.36B | EV / Sales 2024 |
1.28x | EV / Sales 2025 | 1.11x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.72% | ||
| 1 week | -2.55% | ||
| Current month | +3.62% | ||
| 1 month | +3.62% | ||
| 3 months | +4.09% | ||
| Current year | -7.66% |
| 1 week | 2.29 |  | 2.35 |
| 1 month | 2.11 | | 2.46 |
| Current year | 2.08 | | 2.66 |
| 1 year | 2.03 | | 3.16 |
| 3 years | 2.03 | | 4.68 |
| 5 years | 2.03 | | 4.7 |
| 10 years | 1.06 | | 6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 01/03/1999 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01/10/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/03/1999 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | -2.55% | - | - | 25.9M | |
| -1.40% | +3.69% | -2.09% | +11.41% | 49.37B | |
| -2.41% | -0.65% | +406.63% | +629.40% | 40.85B | |
| -1.16% | +13.36% | +22.70% | +3.92% | 39.14B | |
| -1.88% | -3.29% | +5.36% | +40.37% | 35.81B | |
| -1.74% | +8.42% | +8.85% | +48.87% | 30.5B | |
| -2.85% | -3.46% | - | - | 16.55B | |
| -0.21% | -4.74% | +31.83% | +126.49% | 16.14B | |
| -0.64% | +3.09% | +3.15% | +9.37% | 13.71B | |
| -1.19% | -3.97% | -9.88% | -35.13% | 12.77B | |
| Average | -1.52% | +4.67% | +58.32% | +104.34% | 28.32B | |
| Weighted average by Cap. | -1.60% | +5.18% | +76.75% | +130.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.53M 31.67M 25.63M 23.53M 44.43M 3.02B 45.12M 302M 119M 1.51B 119M 116M 5.05B | 28.6M 32.9M 26.62M 24.44M 46.16M 3.14B 46.87M 314M 123M 1.56B 124M 121M 5.24B |
| Net income | 1.83M 2.11M 1.7M 1.56M 2.95M 201M 3M 20.09M 7.88M 100M 7.91M 7.74M 336M | 928K 1.07M 864K 793K 1.5M 102M 1.52M 10.18M 3.99M 50.72M 4.01M 3.92M 170M |
| Net Debt | 623K 717K 580K 532K 1.01M 68.41M 1.02M 6.84M 2.68M 34.06M 2.69M 2.63M 114M | 6.72M 7.73M 6.25M 5.74M 10.84M 738M 11.01M 73.71M 28.93M 367M 29.02M 28.39M 1.23B |
Employees
157
| Date | Price | Change |
|---|---|---|
| 31/07/26 | €2.290 | -1.72% |
| 30/07/26 | €2.330 | -.--% |
| 29/07/26 | €2.330 | -0.43% |
| 28/07/26 | €2.340 | -0.43% |
| 27/07/26 | €2.350 | -0.42% |
- Stock Market
- Stocks
- ALGEN Stock
- JEH Stock
Select your edition
All financial news and data tailored to specific country editions
